193 related articles for article (PubMed ID: 21595923)
1. Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity.
Torres E; Gutierrez-Lopez MD; Mayado A; Rubio A; O'Shea E; Colado MI
J Neuroinflammation; 2011 May; 8():53. PubMed ID: 21595923
[TBL] [Abstract][Full Text] [Related]
2. Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA.
Mayado A; Torres E; Gutierrez-Lopez MD; Colado MI; O'Shea E
J Neuroinflammation; 2011 Nov; 8():165. PubMed ID: 22114930
[TBL] [Abstract][Full Text] [Related]
3. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
Torres E; Gutierrez-Lopez MD; Borcel E; Peraile I; Mayado A; O'Shea E; Colado MI
J Neurochem; 2010 Apr; 113(1):67-78. PubMed ID: 20067581
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
Orio L; O'Shea E; Sanchez V; Pradillo JM; Escobedo I; Camarero J; Moro MA; Green AR; Colado MI
J Neurochem; 2004 Jun; 89(6):1445-53. PubMed ID: 15189347
[TBL] [Abstract][Full Text] [Related]
5. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
Orio L; Llopis N; Torres E; Izco M; O'Shea E; Colado MI
Neurotox Res; 2010 Aug; 18(2):187-99. PubMed ID: 19777321
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.
Touzani O; Boutin H; LeFeuvre R; Parker L; Miller A; Luheshi G; Rothwell N
J Neurosci; 2002 Jan; 22(1):38-43. PubMed ID: 11756486
[TBL] [Abstract][Full Text] [Related]
8. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
9. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.
McNamee EN; Ryan KM; Kilroy D; Connor TJ
Eur J Pharmacol; 2010 Jan; 626(2-3):219-28. PubMed ID: 19818755
[TBL] [Abstract][Full Text] [Related]
10. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
Chipana C; Torres I; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2008 Jun; 54(8):1254-63. PubMed ID: 18455739
[TBL] [Abstract][Full Text] [Related]
11. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
[TBL] [Abstract][Full Text] [Related]
12. THC Prevents MDMA Neurotoxicity in Mice.
Touriño C; Zimmer A; Valverde O
PLoS One; 2010 Feb; 5(2):e9143. PubMed ID: 20174577
[TBL] [Abstract][Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
14. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
15. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
Kirilly E
Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
[TBL] [Abstract][Full Text] [Related]
16. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
Vegting Y; Reneman L; Booij J
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
18. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
Darvesh AS; Shankaran M; Gudelsky GA
J Pharmacol Exp Ther; 2002 Apr; 301(1):138-44. PubMed ID: 11907167
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin.
Preas HL; Reda D; Tropea M; Vandivier RW; Banks SM; Agosti JM; Suffredini AF
Blood; 1996 Oct; 88(7):2465-72. PubMed ID: 8839837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
